190 related articles for article (PubMed ID: 31781500)
1. Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Yin X; Xu A; Fan F; Huang Z; Cheng Q; Zhang L; Sun C; Hu Y
Front Oncol; 2019; 9():1198. PubMed ID: 31781500
[No Abstract] [Full Text] [Related]
2. The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database.
Yin X; Xu A; Huang Z; Fan F; Wang Y; Chen L; Cui G; Hu Y; Sun C
Transl Oncol; 2021 Jul; 14(7):101106. PubMed ID: 33932917
[TBL] [Abstract][Full Text] [Related]
3. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
4. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.
Zhang SL; Chen C; Rao QW; Guo Z; Wang X; Wang ZM; Wang LS
Front Oncol; 2020; 10():750. PubMed ID: 32477954
[No Abstract] [Full Text] [Related]
6. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases.
Møller MB; Pedersen NT; Christensen BE
Br J Haematol; 2004 Jan; 124(2):151-9. PubMed ID: 14687024
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of primary hepatic lymphoma: A US population-based analysis.
Qiu MJ; Fang XF; Huang ZZ; Li QT; Wang MM; Jiang X; Xiong ZF; Yang SL
Transl Oncol; 2021 Jan; 14(1):100931. PubMed ID: 33188980
[TBL] [Abstract][Full Text] [Related]
8. Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database.
Xu H; Yan R; Ye C; Li J; Ji G
Eur J Med Res; 2024 Apr; 29(1):241. PubMed ID: 38643217
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
10. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
11. Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis.
Liu ZH; Yang LC; Song P; Fang K; Zhou J; Peng ZF; Dong Q
Front Oncol; 2021; 11():609882. PubMed ID: 34336635
[TBL] [Abstract][Full Text] [Related]
12. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
13. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
14. Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
Yin X; Chen L; Fan F; Yan H; Zhang Y; Huang Z; Sun C; Hu Y
Front Oncol; 2020; 10():1712. PubMed ID: 33014849
[No Abstract] [Full Text] [Related]
15. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
16. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.
Ohshima K; Kawasaki C; Muta H; Muta K; Deyev V; Haraoka S; Suzumiya J; Podack ER; Kikuchi M
Histopathology; 2001 Aug; 39(2):156-62. PubMed ID: 11493332
[TBL] [Abstract][Full Text] [Related]
17. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
19. Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014.
Jia Y; Sun C; Liu Z; Wang W; Zhou X
Oncotarget; 2018 Jan; 9(3):3956-3967. PubMed ID: 29423097
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
